本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mirum Pharmaceuticals, Inc.

72.76
-0.8100-1.10%
盘后72.760.00000.00%18:41 EDT
成交量:65.45万
成交额:4,720.82万
市值:36.55亿
市盈率:-60.43
高:74.52
开:74.19
低:70.49
收:73.57
52周最高:78.10
52周最低:36.88
股本:5,023.76万
流通股本:3,998.57万
量比:0.50
换手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-1.2041
每股收益(LYR):-1.8505
净资产收益率:-24.19%
总资产收益率:-5.15%
市净率:14.33
市盈率(LYR):-39.32

数据加载中...

公司资料

公司名字:
Mirum Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
2018
员工人数:
349
公司地址:
950 Tower Lane,Suite 1050,Foster City,California,United States
邮编:
94404
电话:
传真:
- -
简介:
Mirum Pharmaceuticals, Inc.于2018年5月2日在特拉华州注册成立。该公司是一家生物制药公司,专注于识别、收购、开发和商业化用于使人衰弱的罕见和孤儿疾病的新疗法。

董事

名称
职位
Christopher Peetz
President and Chief Executive Officer and Director
Michael Grey
Chairman of the Board
Laura Brege
Director
Laurent Fischer
Director
Lon Cardon
Director
Niall O'Donnell
Director
Patrick Heron
Director
Saira Ramasastry
Director
Timothy Walbert
Director
William Fairey
Director

股东

名称
职位
Christopher Peetz
President and Chief Executive Officer and Director
Peter Radovich
Chief Operating Officer
Lara Longpre
Chief Development Officer
Pamela Vig
Head of Research and Development